Welcome to the CCO Site

Thank you for your interest in CCO content. As a guest, please complete the following information fields. These data help ensure our continued delivery of impactful education. 

Become a member (or login)? Member benefits include accreditation certificates, downloadable slides, and decision support tools.

Submit

Part 1: Risk Factors (10 minutes)

Learn who is at risk and what you can do about it.
Terry D. Box, MD
Released: March 17, 2020 Expiration: No longer available for credit

This program is divided into short segments that you can review from the Activity landing page. After reviewing all segments, click the Claim Credit button to complete the CME posttest and evaluation.
PreviousNext

Related Content

Unlocked slides from Wing-Kin Syn, MBChB, PhD, FACP, FRCP and CCO: How to use biomarkers and imaging to evaluate NAFLD and NASH—ruling in or out hepatic fibrosis

Wing-Kin Syn, MBChB, PhD, FACP, FRCP Released: April 27, 2021

Expert commentary discussing the early identification and prognosis of NAFLD, from Clinical Care Options (CCO)

Manal F. Abdelmalek, MD, MPH Physicians: maximum of 0.25 AMA PRA Category 1 Credits Registered Nurses: 0.25 Nursing contact hours Pharmacists: 0.25 contact hours (0.025 CEUs) Released: March 16, 2021 Expired: March 15, 2022

Unlocked slides from Manal Abdelmalek, MD, MPH, and CCO: Who is at risk and who should be evaluated for progression to advanced fibrosis in NASH?

Manal F. Abdelmalek, MD, MPH Released: March 15, 2021

Video Chapters


Provided by Clinical Care Options, LLC

Contact Clinical Care Options

For customer support please email: customersupport@clinicaloptions.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Produced in collaboration with
National Rural Health Association Logo
Supported by educational grants from
Mallinckrodt Pharmaceuticals
Salix Pharmaceuticals

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue